Skip to main content
. Author manuscript; available in PMC: 2016 May 3.
Published in final edited form as: J Acquir Immune Defic Syndr. 2015 Mar 1;68(Suppl 2):S114–S123. doi: 10.1097/QAI.0000000000000439

Table 2.

Characteristics and factors associated with engagement in TasP among HIV-positive Men who have Sex with Men (MSM) in Nigeria. Unadjusted odds ratios (OR) with 95% confidence interval (CI).

TOTAL Not Engaged in TasP Engaged in TasP P Crude OR (95% CI)
n Row % n Row %
58 45.3 70 54.7
Age, years
 16–20 9 42.9 12 57.1 0.119 Ref.
 21–25 27 57.5 20 42.6 0.56 (0.20, 1.57)
 26–30 18 40.9 26 59.1 1.08 (0.38, 3.10)
 31+ 4 25.0 12 75.0 2.25 (0.54, 9.34)
Education
 Never, Quranic, Primary: <=primary 7 43.8 9 56.3 0.628 Ref.
 JSS 4 40.0 6 60.0 1.17 (0.23, 5.81)
 SSS 30 51.7 28 48.3 0.73 (0.24, 2.21)
 Higher SSS 16 39.0 25 61.0 1.22 (0.38, 3.92)
Occupation
 Not Working 18 47.4 20 52.6 0.398 Ref.
 Student 30 41.1 43 58.9 1.29 (0.59, 2.84)
 Working 10 58.8 7 41.2 0.63 (0.20, 2.00)
Religion
 Christian 32 37.7 53 62.4 0.010 Ref.
 Muslim & Other 26 63.4 16 38.1 0.37 (0.17, 0.80)
Marital Status
 Married/Cohabiting with woman 10 66.7 5 33.3 0.148 Ref.
 Divorces, separated, widowed 3 30.0 7 70.0 4.67 (0.83, 26.23)
 Single, never married 45 43.7 55 56.3 2.58 (0.82, 8.01)
Sexual Orientation
 Gay, Homosexual 14 37.8 23 61.2 0.279 Ref.
 Bisexual 44 48.4 47 51.7 0.65 (0.30, 1.42)
Told family MSM Status
 No 53 50.5 52 49.5 0.018 Ref.
 Yes 5 22.7 17 77.3 3.47 (1.19, 10.08)
Told health care worker MSM Status
 No 46 51.7 43 48.3 0.018 Ref.
 Yes 11 29.0 27 71.1 2.63 (1.16, 5.93)
Disclosure of MSM status
 None 42 53.9 36 46.2 0.023 Ref.
 Family only 4 40.0 6 60.0 1.75 (0.46, 6.69)
 Health care worker only 10 38.5 16 61.5 1.87 (0.75, 4.62)
 Both 1 8.3 11 91.7 12.83 (1.58, 104.26)
HIV Characteristics at Baseline
CD4, cells/uL Binary
 <200 10 37.0 17 63.0 0.001 Ref.
 200–349 16 32.0 33 68.0 1.25 (0.47, 3.34)
 ≥350 30 69.8 11 30.2 0.26 (0.09, 0.71)
Viral load, copies/ml
 <10,000 8 61.5 5 38.5 0.240 Ref.
 10,000–99,999 23 48.9 23 51.1 1.67 (0.48, 5.85)
 ≥100,000 20 37.7 32 62.3 2.64 (0.76, 9.19)
WHO Stage
 1 53 49.1 55 50.9 0.047 Ref.
 2 5 25.0 15 75.0 2.89 (0.98, 8.51)